Article

Diclofenac Sodium 1% Gel Helps Reduce Osteoarthritis Pain

Diclofenac sodium 1% gel, a nonsteroidal anti-inflammatory treatment, was found to be superior to vehicle gel for reducing osteoarthritis pain in the finger joints in a study presented at the American College of Sports Medicine’s 59th Annual Meeting in San Francisco.

Diclofenac sodium 1% gel (DSG), a nonsteroidal anti-inflammatory treatment, was found to be superior to vehicle gel for reducing osteoarthritis (OA) pain in the finger joints in a study presented at the American College of Sports Medicine’s 59th Annual Meeting in San Francisco. There also was a trend toward improvement in stiffness and function.

Patients aged 40 years and older with hand OA applied DSG or a vehicle/placebo gel 4 times daily for 8 weeks. Researchers assessed pain intensity using a Visual Analog Scale and measured pain, stiffness, and function with AUStralian/CANadian Osteoarthritis Hand Index subscales. They compared the effectiveness of the topical treatments in patients with OA in the first carpometacarpal joint, first carpometacarpal plus interphalangeal joints, and interphalangeal joints only. Limiting treatment to the affected finger joints with topical DSG may be preferable for those patients who wish to minimize systemic NSAID exposure, it was noted.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.